Follow the HLB생명과학 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, HLB생명과학 has published 31 reports. Market capitalisation: €372.9bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: HLB. The full history is accessible without an account.
31
Insider Decl.
0
Thresholds
·
13 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.